Neoadjuvant radio-chemotherapy in advanced primarily non-resectable carcinomas of the pancreas

European Journal of Surgical Oncology

Volumn 26, Issue 6, 2000, Pages 578-582

  Kastl, S ^a   Brunner, T ^a   Herrmann, O ^a   Riepl, M ^a,b   Fietkau, R ^a,b   Grabenbauer, G ^a   Sauer, R ^a   Hohenberger, W ^a   Klein, P ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Multimodal therapy; Pancreatic cancer; Radio chemotherapy; Resection rate

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; MITOMYCIN C;

ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PANCREAS CARCINOMA; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME;

EID: 0033791030     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2000.0950     Document Type: Article

References (35)

1. Surgical results and indications for adjuvant measures in pancreatic cancer
2. Evolving strategies for the treatment of adenocarcinoma of the pancreas. A review
3. Intraoperative radiotherapy for pancreatic carcinoma
4. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum
5. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas
6. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the head of the pancreas
7. Future prospect of radiotherapy in pancreatic cancer
8. Preoperative chemoradiotherapy for localized pancreatic carcinoma
9. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma
10. Neoadjuvant chemoradiation in pancreatic and duodena carcinoma. A phase II study
11. Pancreatic Cancer
12. Treatment and survival in 13 560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands, an epidemiological study
13. Pancreatic adenocarcinoma: Epidemiology and genetics
14. The National Cancer Data Base report on pancreatic cancer
15. Surgical treatment of ductal pancreatic carcinoma
16. Effectiveness of multimodality treatment for resectable pancreatic cancer
17. Recurrence after resection for ductal adenocarcinoma of the pancreas
18. Adjuvant therapy of resected adenocarcinoma of the pancreas
19. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An Eastern cooperative oncology group study
20. Pancreatic cancer: Value of dual-phase helical CT in assessing resectability
21. Local staging of pancreatic cancer: Criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT
22. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
23. Overview: Late effects of normal tissues (lent) scoring system
24. Unresectable pancreatic cancer: Is a multi-modality approach a promising therapeutical alternative?
25. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer
26. Current management of pancreatic carcinoma
27. Resection margins in carcinoma of the head of the pancreas: Implications for radiation therapy
28. Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience
29. Chemotherapy for pancreatic carcinoma
30. Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ± 5-fluorouracil
31. Adjuvant radiotherapy and 5-fluorouracile after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group
32. Combined modality treatment of localized unresectable adenocarcinoma of the pancreas
33. Adjuvant therapy for pancreatic cancer
34. Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-months chemotherapy, and combination therapy vs. neo-adjuvant treatment in resectable pancreatic cancer (ESPAC-1)
35. A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas